Arama Sonuçları - Hatschek, Thomas

A Five-year Follow-up of Quality of Life in Women with Breast Cancer in Anthroposophic and Conventional Care Yazar: Carlsson, Marianne, Arman, Maria, Backman, Marie, Flatters, Ursula, Hatschek, Thomas, Hamrin, Elisabeth

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide Yazar: von Stedingk, Hans, Xie, Hanjing, Hatschek, Thomas, Foukakis, Theodoros, Rydén, Andreas, Bergh, Jonas, Rydberg, Per

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Claudin‐2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences Yazar: Kimbung, Siker, Kovács, Anikó, Bendahl, Pär-Ola, Malmström, Per, Fernö, Mårten, Hatschek, Thomas, Hedenfalk, Ingrid

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer Yazar: Zetterlund, Linda Holmstrand, Frisell, Jan, Zouzos, Athanasios, Axelsson, Rimma, Hatschek, Thomas, de Boniface, Jana, Celebioglu, Fuat

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single Cell Sequencing Yazar: Kim, Charissa, Gao, Ruli, Sei, Emi, Brandt, Rachel, Hartman, Johan, Hatschek, Thomas, Crosetto, Nicola, Foukakis, Theodoros, Navin, Nicholas

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Transcriptomic and functional pathway features were associated with survival after pathological complete response to neoadjuvant chemotherapy in breast cancer Yazar: Takeshita, Takashi, Yan, Li, Peng, Xuan, Kimbung, Siker, Hatschek, Thomas, Hedenfalk, Ingrid A, Rashid, Omar M, Takabe, Kazuaki

Tam Metin Erişim Tam Metin Erişim

Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs) Yazar: Kjällquist, Una, Erlandsson, Rikard, Tobin, Nicholas P., Alkodsi, Amjad, Ullah, Ikram, Stålhammar, Gustav, Karlsson, Eva, Hatschek, Thomas, Hartman, Johan, Linnarsson, Sten, Bergh, Jonas

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Protein profiling of fine‐needle aspirates reveals subtype‐associated immune signatures and involvement of chemokines in breast cancer Yazar: Franzén, Bo, Alexeyenko, Andrey, Kamali‐Moghaddam, Masood, Hatschek, Thomas, Kanter, Lena, Ramqvist, Torbjörn, Kierkegaard, Jonas, Masucci, Giuseppe, Auer, Gert, Landegren, Ulf, Lewensohn, Rolf

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer Yazar: Zerdes, Ioannis, Karafousia, Vaia, Mezheyeuski, Artur, Stogiannitsi, Maria, Kuiper, Raoul, Moreno Ruiz, Pablo, Rassidakis, George, Bergh, Jonas, Hatschek, Thomas, Foukakis, Theodoros, Matikas, Alexios

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer Yazar: Matikas, Alexios, Lövrot, John, Ramberg, Anna, Eriksson, Margareta, Lindsten, Therese, Lekberg, Tobias, Hedenfalk, Ingrid, Loman, Niklas, Bergh, Jonas, Hatschek, Thomas, Erlandsson, Ann, Foukakis, Theodoros

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

A fine‐needle aspiration‐based protein signature discriminates benign from malignant breast lesions Yazar: Franzén, Bo, Kamali‐Moghaddam, Masood, Alexeyenko, Andrey, Hatschek, Thomas, Becker, Susanne, Wik, Lotta, Kierkegaard, Jonas, Eriksson, Annika, Muppani, Naveen R., Auer, Gert, Landegren, Ulf, Lewensohn, Rolf

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers Yazar: Haugen, Mads H., Lingjærde, Ole Christian, Hedenfalk, Ingrid, Garred, Øystein, Borgen, Elin, Loman, Niklas, Hatschek, Thomas, Børresen-Dale, Anne-Lise, Naume, Bjørn, Mills, Gordon B., Mælandsmo, Gunhild M., Engebraaten, Olav

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression Yazar: Palazon, Asis, Tyrakis, Petros A., Macias, David, Veliça, Pedro, Rundqvist, Helene, Fitzpatrick, Susan, Vojnovic, Nikola, Phan, Anthony T., Loman, Niklas, Hedenfalk, Ingrid, Hatschek, Thomas, Lövrot, John, Foukakis, Theodoros, Goldrath, Ananda W., Bergh, Jonas, Johnson, Randall S.

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results... Yazar: Kimbung, Siker, Markholm, Ida, Bjöhle, Judith, Lekberg, Tobias, von Wachenfeldt, Anna, Azavedo, Edward, Saracco, Ariel, Hellström, Mats, Veerla, Srinivas, Paquet, Eric, Bendahl, Pär‐Ola, Fernö, Mårten, Bergh, Jonas, Loman, Niklas, Hatschek, Thomas, Hedenfalk, Ingrid

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients Yazar: Tobin, Nicholas P., Lundberg, Arian, Lindström, Linda S., Harrell, J. Chuck, Foukakis, Theodoros, Carlsson, Lena, Einbeigi, Zakaria, Linderholm, Barbro K., Loman, Niklas, Malmberg, Martin, Fernö, Mårten, Czene, Kamila, Perou, Charles M., Bergh, Jonas, Hatschek, Thomas

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Immune gene expression and response to chemotherapy in advanced breast cancer Yazar: Foukakis, Theodoros, Lövrot, John, Matikas, Alexios, Zerdes, Ioannis, Lorent, Julie, Tobin, Nick, Suzuki, Chikako, Brage, Suzanne Egyházi, Carlsson, Lena, Einbeigi, Zakaria, Linderholm, Barbro, Loman, Niklas, Malmberg, Martin, Fernö, Mårten, Skoog, Lambert, Bergh, Jonas, Hatschek, Thomas

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Separation of breast cancer and organ microenvironment transcriptomes in metastases Yazar: Alzubi, Mohammad A., Turner, Tia H., Olex, Amy L., Sohal, Sahib S., Tobin, Nicholas P., Recio, Susana G., Bergh, Jonas, Hatschek, Thomas, Parker, Joel S., Sartorius, Carol A., Perou, Charles M., Dozmorov, Mikhail G., Harrell, J. Chuck

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production Yazar: Nakamura, Masaki, Zhang, Yin, Yang, Yunlong, Sonmez, Ceylan, Zheng, Wenyi, Huang, Guichun, Seki, Takahiro, Iwamoto, Hideki, Ding, Bo, Yin, Linlin, Foukakis, Theodoros, Hatschek, Thomas, Li, Xuri, Hosaka, Kayoko, Li, Jiaping, Yu, Guohua, Wang, Xinsheng, Liu, Yizhi, Cao, Yihai

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim

Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial Yazar: Hatschek, Thomas, Foukakis, Theodoros, Bjöhle, Judith, Lekberg, Tobias, Fredholm, Hanna, Elinder, Ellinor, Bosch, Ana, Pekar, Gyula, Lindman, Henrik, Schiza, Aglaia, Einbeigi, Zakaria, Adra, Jamila, Andersson, Anne, Carlsson, Lena, Dreifaldt, Ann Charlotte, Isaksson-Friman, Erika, Agartz, Susanne, Azavedo, Edward, Grybäck, Per, Hellström, Mats, Johansson, Hemming, Maes, Claudia, Zerdes, Ioannis, Hartman, Johan, Brandberg, Yvonne, Bergh, Jonas

Tam Metin Erişim Tam Metin Erişim Tam Metin Erişim